oasis 1 oral semaglutide 50 mg obesity nejm 2023 results Daily GLP-1 Receptor Agonist Orforglipron for Adults with Oral Semaglutide 25 mg and

In patients with type 1 and type 2 diabetes, there is reduced secretion from pancreatic beta cells of both insulin and amylin in response to food

The primary headaches as a reflection of genetic darwinian adaptive behavioral responses

Not only are patients with T2D more likely to see a cardiologist than an endocrinologist especially those with ASCVD but cardiologists are also trusted advisors in reducing CV risks [189]

Preprint at (2016)

" 100

Another possibility is that GIP reduces the metabolic adaptation that typically occurs during weight loss, where energy expenditure decreases more than predicted by changes in body mass